TY - JOUR KW - Buruli ulcer KW - Cost of Illness KW - Health economics KW - Illness costs KW - Mycobacterium ulcerans KW - Nigeria AU - Chukwu JN AU - Meka A AU - NWAFOR C AU - Oshi DC AU - MADICHIE N AU - Ekeke N AU - Anyim MC AU - Chukwuka A AU - Obinna M AU - Adegbesan J AU - Njoku M AU - Soyinka FO AU - Adelokiki AO AU - Enemuoh I AU - Okolie PI AU - Edochie JE AU - Offor J AU - Ushaka J AU - Ukwaja KN AB -

BACKGROUND: The economic burden of Buruli ulcer for patients has not been well-documented. This study assessed the costs of Buruli ulcer care to patients from the onset of illness to diagnosis and to the end of treatment.

METHODS: This was a cross-sectional cost of illness study conducted among patients with Buruli ulcer in four States in Nigeria between July and September 2015. A structured questionnaire was used to collect data on the patients' characteristics, household income and out-of-pocket costs of care.

RESULTS: Of 92 patients surveyed, 54 (59%) were older than 15years, 49 (53%) were males, and 86 (93%) resided in a rural area. The median (IQR) direct medical and non-medical cost per patient was US$124 (50-282) and US$3 (3-6); corresponding to 149% and 4% of the patients' median monthly household income, respectively. The overall direct costs per patient was US$135 (58-327), which corresponded to 162% of median monthly household income, with pre-diagnosis costs accounting for 94.8% of the total costs. The direct costs of Buruli ulcer care were catastrophic for 50% of all patients/households - the rates of catastrophic costs for Buruli ulcer care was 66% and 19% for patients belonging to the lowest and highest income quartiles, respectively.

CONCLUSIONS: Direct costs of Buruli ulcer diagnosis and treatment are catastrophic to a substantial proportion of patients and their families.

BT - International health C1 -

http://www.ncbi.nlm.nih.gov/pubmed/27986841?dopt=Abstract

DO - 10.1093/inthealth/ihw056 IS - 1 J2 - Int Health LA - eng N2 -

BACKGROUND: The economic burden of Buruli ulcer for patients has not been well-documented. This study assessed the costs of Buruli ulcer care to patients from the onset of illness to diagnosis and to the end of treatment.

METHODS: This was a cross-sectional cost of illness study conducted among patients with Buruli ulcer in four States in Nigeria between July and September 2015. A structured questionnaire was used to collect data on the patients' characteristics, household income and out-of-pocket costs of care.

RESULTS: Of 92 patients surveyed, 54 (59%) were older than 15years, 49 (53%) were males, and 86 (93%) resided in a rural area. The median (IQR) direct medical and non-medical cost per patient was US$124 (50-282) and US$3 (3-6); corresponding to 149% and 4% of the patients' median monthly household income, respectively. The overall direct costs per patient was US$135 (58-327), which corresponded to 162% of median monthly household income, with pre-diagnosis costs accounting for 94.8% of the total costs. The direct costs of Buruli ulcer care were catastrophic for 50% of all patients/households - the rates of catastrophic costs for Buruli ulcer care was 66% and 19% for patients belonging to the lowest and highest income quartiles, respectively.

CONCLUSIONS: Direct costs of Buruli ulcer diagnosis and treatment are catastrophic to a substantial proportion of patients and their families.

PY - 2017 EP - 36–43 T2 - International health TI - Financial burden of health care for Buruli ulcer patients in Nigeria: the patients' perspective. UR - https://academic.oup.com/inthealth/article/9/1/36/2701616 VL - 9 SN - 1876-3405 ER -